xIPOmeter
Freenome
Gráfico NewsHeat
- Semana
- Mes
- Año
- Noticias de prensa
- Noticias corporativas
Los datos del gráfico anterior se basan en datos derivados de nuestro modelo de cálculo XP patentado y pueden modificarse, ajustarse y actualizarse sin previo aviso.
Valoración de empresas
- Valoración
- Precio de las acciones
- Financiación acumulada
Los datos de los cuadros y gráficos se basan en datos de fuentes públicas y, aunque hacemos todo lo posible por recopilarlos, es posible que no coincidan con los datos reales del emisor.
*** - Para ver los datos, conéctese a su cuenta o cree una nueva.
Calculadora de valoración de empresas
Para calcular, especifique uno de los parámetros
Noticias relacionadas con Freenome6
FreenomeFreenome CEO Mike Nolan exits cancer test maker - San Francisco ...
Freenome appointed co-founder Riley Ennis as head of an interim office of the CEO. He will be assisted by former NeoGenomics CEO Douglas VanOort. Ennis has been ...
https://www.bizjournals.com/sanfrancisco/news/2024/09/25/cancer-test-freenome-ceo-exit-mike-nolan.htmlFreenomeFreenome Announces CEO Transition
Freenome is a biotechnology company pioneering an early cancer detection platform. (PRNewsfoto/Freenome. News provided by. Freenome Holdings, Inc....
https://www.prnewswire.com/news-releases/freenome-announces-ceo-transition-302259012.htmlFreenomeCanaccord positive on Exact, Guardant after Freenome data ...
Canaccord positive on Exact, Guardant after Freenome data. See the rest of the story here. Theflyonthewall.com provides the latest financial news as it ...
https://pro.thestreet.com/thefly-newsbreaks/exas-gh-canaccord-positive-on-exact-guardant-after-freenome-dataFreenomeExact Sciences Stock, A Cathie Wood's Play, Surges On Freenome's ...
Freenome is working on a blood-based test to detect colorectal cancer. Overall, Freenome's test proved roughly as specific as Exact Sciences' stool-based test, ...
https://www.investors.com/news/technology/exact-sciences-stock-cologuard-freenome-colon-cancer-detection/FreenomeFreenome Announces Topline Results for PREEMPT CRC® to ...
Freenome is breaking barriers to early cancer detection with a suite of blood tests built on its multiomics platform. The company recognizes that no single ...
https://www.prnewswire.com/news-releases/freenome-announces-topline-results-for-preempt-crc-to-validate-the-first-version-of-its-blood-based-test-for-the-early-detection-of-colorectal-cancer-302105203.html
Ver más (1)Inversores23
Andreessen Horowitz
Third Kind Venture Capital
Founders Fund
Data Collective DCVC
Polaris Partners
S28 Capital
AME Cloud Ventures
Charles River Associates
Allen & Company
GV
Asset Management Ventures (AMV)
Innovation Endeavors
CRV
Verily
Section 32
Artis Ventures (AV)
T. Rowe Price
BrightEdge Fund
Roche Venture Fund
Kaiser Permanente Ventures
RA Capital Management
Perceptive Advisors
Loxbridge Research